(Q34774226)

English

Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

5

object named as

Naoki Yamamoto

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Hiroshi Terunuma

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Xuewen Deng

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Zahidunnabi Dewan

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Shigeyoshi Fujimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

International Reviews of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

93-110

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

NK cell receptors

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

HLA and KIR polymorphisms affect NK-cell anti-tumor activity.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Close encounters of different kinds: dendritic cells and NK cells take centre stage

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

A contribution of mouse dendritic cell-derived IL-2 for NK cell activation

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

NK cell and DC interactions

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Anticoagulant drugs increase natural killer cell activity in lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Adoptive immunotherapy for cancer: building on success

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

The changing role of natural killer cells in solid organ rejection and tolerance

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Dendritic cell immunotherapy: mapping the way.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1080%2F08830180801911743

21 January 2018

Identifiers

10.1080/08830180801911743

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34774226&oldid=1988840599"